ArticleOncology letters2018

Immunological effects of a low-dose cytarabine, aclarubicin and granulocyte-colony stimulating factor priming regimen on a mouse leukemia model.

Jinqiu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.